Skip to main content
. 2021 Sep 15;9(9):e3809. doi: 10.1097/GOX.0000000000003809

Fig. 6.

Fig. 6.

Facial volumetric changes following treatment with Teprotumumab. Ai and Aii, Pretreatment. Bi and Bii, Posttreatment. C, topographical representation of facial volume loss across the face (only regions with the greatest volume loss depicted).